A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific world. Developed from a ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

According to the WHO, meningitis is a significant global health threat even though treatments and vaccines against some forms are available.

Meningococcal disease is a severe, fast-progressing infection; vaccination is key for high-risk groups, preventing ...

In a disease outbreak update, the WHO said Saudi officials reported 11 confirmed cases of IMD on March 13. All 11 cases were associated with pilgrims who had performed Umrah in Saudi Arabia from ...

GSK plc GSK announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization ...

An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ago, the introduction of CRISPR technology marked a significant breakthrough ...

GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule.

For the first time, Professor Veyrier and his team at INRS have discovered a family of enzymes that can cut specific sequences in single-stranded DNA. These enzymes, called site-specific ...

The CDC’s Advisory Committee on Immunization Practices voted April 16 to expand use of respiratory syncytial virus vaccines among high-risk adults. The updated recommendation calls for a single ...

We are in the peak meningitis season, and the risk of transmission is high due to dry, dusty weather and overcrowding.